Leveraging GWAS Findings to Map Variants and Identify Novel Effector Genes for Alcohol-Related Traits
利用 GWAS 研究结果绘制变异图谱并识别酒精相关特征的新效应基因
基本信息
- 批准号:10657933
- 负责人:
- 金额:$ 64.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalATAC-seqAddressAdultAffectAfrican ancestryAlcohol abuseAlcohol consumptionAlcoholsBehavioralBiologicalBiological ModelsBiological ProcessCRISPR/Cas technologyCandidate Disease GeneCellsCessation of lifeChromatinChromosome MappingClinicalClustered Regularly Interspaced Short Palindromic RepeatsCodeDataData SetDevelopmentDiagnosisDiagnosticDrosophila genusDrosophila melanogasterElectronic Health RecordElementsEnhancersEpigenetic ProcessEuropean ancestryGene ExpressionGenesGeneticGenomicsHeavy DrinkingHeritabilityHi-CHumanIndividualInduced pluripotent stem cell derived neuronsLaboratoriesLatinoLightLinkMapsMeasuresMedicalMeta-AnalysisMethodsModelingMolecular GeneticsNeighborhoodsNeuronsNeurotransmittersOrthologous GenePathway AnalysisPathway interactionsPhenotypePopulationPreventionPublic HealthRegulatory ElementReportingResolutionResourcesSamplingSingle Nucleotide PolymorphismSystemTestingTherapeuticTimeTwin Multiple BirthUntranslated RNAVariantVeteransalcohol behavioralcohol effectalcohol related genealcohol use disorderbinge drinkingbiobankcandidate identificationcausal variantcomorbiditydata integrationdopaminergic neuronexomeflygenetic architecturegenetic manipulationgenetic variantgenome wide association studygenome-wideinduced pluripotent stem cellinnovationknock-downnovelnovel strategiesoverexpressionphenomepleiotropismpreferenceprogramspromoterpsychosocialrare variantrisk varianttraittranscriptome sequencing
项目摘要
More than one-quarter of U.S. adults report past-year binge drinking and 5.6% meet criteria for a past-year
alcohol use disorder (AUD). These traits are associated with psychosocial disruption, medical co-morbidities,
and nearly 10% of all U.S. deaths annually. Alcohol consumption and AUD have an estimated twin heritability
of 43% and 49%, respectively. Genome-wide association studies (GWAS) of these traits have identified 380
genome-wide significant SNPs in 155 loci. In this revised application, we propose to use a “variant to gene
mapping to clinical impact” approach, intersecting GWAS data with ATAC-seq and high-resolution promoter-
focused Capture C neuronal datasets derived from human induced pluripotent stem cells (iPSCs) to identify
potential effector genes. To prioritize SNPs, we will focus on those residing in open chromatin and with
enhancer epigenetic marks; we will also use eQTL resources, as needed. We will validate these and newly
identified candidates in three ways: 1) in established Drosophila models of alcohol behavioral effects, 2) initially
with human iPSC-derived cortical and dopaminergic neurons and subsequently with neurons of other
neurotransmitter systems, as indicated, to delete the genomic neighborhood harboring a putative causal
variant to determine its effects on the gene's expression, and 3) with data from 4 biobanks to corroborate the
association of the functionally validated genes with alcohol-related phenotypes. In Aim 1, we will expand our
preliminary set of 43 loci from iPSC-derived cortical neurons, initially by applying similar methods to iPSC-
derived dopaminergic neurons and other neuronal types, as indicated. In Aim 2a, we will screen candidate
genes identified in preliminary findings and those identified in Aim 1 by knocking down or over-expressing their
orthologs in fly models of alcohol consumption, preference, sensitivity, and tolerance. In Aim 2b, we will use
SNP-CRISPR in human iPSC-derived neurons to test whether deleting the genomic neighborhood of putative
causal variants from preliminary data or those identified in Aim 1 affects expression of their target gene(s). In
Aim 3, we will use array and exome sequence data from both European- and African-ancestry individuals to
validate all putative effector genes by examining their association with alcohol-related traits, conducting
downstream analyses, testing rare variant effects, and examining pleiotropy in phenome-wide association
studies. This project will identify novel genetic variants and the corresponding effector genes that contribute to
alcohol-related traits, thereby shedding light on the biological pathways that influence the development of the
traits. Study results will have fundamental implications for novel approaches to the diagnosis, prevention, and
treatment of heavy drinking and AUD.
超过四分之一的美国成年人报告在过去一年中酗酒,5.6%的人符合过去一年的标准
酒精使用障碍(AUD)。这些特征与心理社会混乱、医学共病、
占美国每年死亡人数的近10%。据估计,饮酒和AUD具有孪生遗传性
分别为43%和49%。对这些性状的全基因组关联研究(GWAS)已经确定了380个
155个基因座的全基因组显著SNPs。在这个修改后的申请中,我们建议使用一种“基因的变体”
映射到临床影响“的方法,将Gwas数据与ATAC-SEQ和高分辨率启动子-
从人诱导多能干细胞(IPSCs)获得的聚焦捕获C神经元数据集用于鉴定
潜在的效应基因。为了确定SNPs的优先顺序,我们将重点关注那些存在于开放染色质和
增强表观遗传标记;我们还将根据需要使用eQTL资源。我们将验证这些和新的
通过三种方式确定候选者:1)在已建立的酒精行为影响的果蝇模型中,2)最初
与人IPSC来源的皮质和多巴胺能神经元以及随后与其他
神经递质系统,如图所示,删除含有推定原因的基因组邻域
变种以确定其对基因表达的影响,以及3)使用来自4个生物库的数据来证实
功能验证基因与酒精相关表型的关联。在目标1中,我们将扩大我们的
来自IPSC皮质神经元的43个基因座的初步设置,最初是通过对IPSC应用类似的方法-
衍生的多巴胺能神经元和其他神经元类型,如图所示。在目标2a中,我们将筛选候选人
在初步发现中确定的基因和在目标1中通过敲除或过度表达其基因而确定的基因
果蝇模型中的酒精消耗量、偏好、敏感性和耐受性的同源基因。在目标2b中,我们将使用
SNP-CRISPR在人IPSC来源神经元中检测是否删除假定的基因组邻域
初步数据的因果变异或AIM 1中确定的变异会影响其目标基因的表达(S)。在……里面
目标3,我们将使用来自欧洲和非洲血统的个体的阵列和外显子组序列数据来
通过检查它们与酒精相关特征的关联来验证所有假定的效应基因,进行
下游分析,测试罕见的变异效应,并检查表型范围内的多效性
学习。该项目将识别新的遗传变异和相应的效应基因,这些基因有助于
与酒精相关的特征,从而揭示了影响酒精发育的生物途径
特征。研究结果将对新的诊断、预防和治疗方法具有重要意义。
酗酒和AUD的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Struan F A Grant其他文献
Struan F A Grant的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Struan F A Grant', 18)}}的其他基金
Discovery of osteoblast and osteoclast bone mass effector genes using advanced genomics
利用先进基因组学发现成骨细胞和破骨细胞骨量效应基因
- 批准号:
10675631 - 财政年份:2022
- 资助金额:
$ 64.63万 - 项目类别:
Discovery of osteoblast and osteoclast bone mass effector genes using advanced genomics
利用先进基因组学发现成骨细胞和破骨细胞骨量效应基因
- 批准号:
10362112 - 财政年份:2022
- 资助金额:
$ 64.63万 - 项目类别:
Genomics of bone and body composition traits in children
儿童骨骼和身体成分特征的基因组学
- 批准号:
10441340 - 财政年份:2020
- 资助金额:
$ 64.63万 - 项目类别:
Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice
人类干细胞衍生模型和小鼠中 T2D 相关基因的功能研究
- 批准号:
10649538 - 财政年份:2020
- 资助金额:
$ 64.63万 - 项目类别:
Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice
人类干细胞衍生模型和小鼠中 T2D 相关基因的功能研究
- 批准号:
10451608 - 财政年份:2020
- 资助金额:
$ 64.63万 - 项目类别:
Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice
人类干细胞衍生模型和小鼠中 T2D 相关基因的功能研究
- 批准号:
10242941 - 财政年份:2020
- 资助金额:
$ 64.63万 - 项目类别:
Genomics of bone and body composition traits in children
儿童骨骼和身体成分特征的基因组学
- 批准号:
10663174 - 财政年份:2020
- 资助金额:
$ 64.63万 - 项目类别:
Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice
人类干细胞衍生模型和小鼠中 T2D 相关基因的功能研究
- 批准号:
10064866 - 财政年份:2020
- 资助金额:
$ 64.63万 - 项目类别:
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches
使用 3D 表观基因组学和单细胞方法研究 T1D 风险变异及其靶基因的功能机制
- 批准号:
9987848 - 财政年份:2019
- 资助金额:
$ 64.63万 - 项目类别:
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches
使用 3D 表观基因组学和单细胞方法研究 T1D 风险变异及其靶基因的功能机制
- 批准号:
10398021 - 财政年份:2019
- 资助金额:
$ 64.63万 - 项目类别:
相似国自然基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
- 批准号:81802809
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
- 批准号:31802046
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
- 批准号:31801915
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
- 批准号:31871331
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
- 批准号:
10806548 - 财政年份:2023
- 资助金额:
$ 64.63万 - 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
- 批准号:
10210424 - 财政年份:2018
- 资助金额:
$ 64.63万 - 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
- 批准号:
1714070 - 财政年份:2017
- 资助金额:
$ 64.63万 - 项目类别:
Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
- 批准号:
10558379 - 财政年份:2001
- 资助金额:
$ 64.63万 - 项目类别: